Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-09-08
1998-02-17
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142278, 5142282, 5142312, 5142315, 5142335, 5142338, 5142352, 5142358, 5142362, 5142365, 5142368, 5142372, 544 59, 544 60, 544 61, 544 62, 544 581, 544 584, 544111, 544106, 544114, 544122, 544128, 544129, 544132, 544133, 544137, 544139, 544140, 544141, 544143, 544145, 544146, 544148, 544152, 544153, A61K 3154, A61K 31535, C07D41304, C07D41704, C07D27912, C07D26530
Patent
active
057191476
ABSTRACT:
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
REFERENCES:
patent: 2943022 (1960-06-01), Siemer et al.
patent: 3005818 (1961-10-01), Siemer et al.
patent: 3458509 (1969-07-01), Levine et al.
patent: 3506673 (1970-04-01), Warawa et al.
patent: 3541090 (1970-11-01), Herlinger et al.
patent: 4010266 (1977-03-01), McLoughlin et al.
patent: 4360519 (1982-11-01), White et al.
patent: 4476311 (1984-10-01), Shetty et al.
patent: 4705553 (1987-11-01), Buschmenn et al.
patent: 4782054 (1988-11-01), Regnier et al.
patent: 4943578 (1990-07-01), Naylor et al.
patent: 5064838 (1991-11-01), Carr et al.
patent: 5095021 (1992-03-01), Zipplies et al.
patent: 5457107 (1995-10-01), Kaufman
patent: 5512570 (1996-04-01), Dorn et al.
Advenier et al., "Neurokinin A (NK2) Receptor Revisited With SR48968 . . . ", Biochem. and Biophys., Res. Comm.; 184(3), pp. 1418-1424 (1992).
Edmonds-Alt, et al., "A Potent and Selective Non-Peptide Antagonist of the Neurokinin A (NK2) Receptor." Life Sci., 50, pp. PL101-PL106 (1992).
Frossard, et al. "Tachykinin Receptors and the Airways", Life Sci., 49, pp. 1491-1953, (1991).
Guthrie, et al., "The Use of Periodate-Oxidized Glycosides in the Robinson-Schopf . . . ", J. Chem. Society, vol. C(1), pp. 62-66 (1967).
Howson, et al., "An SAR Study for the Non-Peptide Substance P Receptor . . . ", Biorg. & Med Chem. Lett., vol. 2(6), pp. 559-564 (1992).
G. Rucker, et al., Arch. Pharm.,(Weinheim, Ger.) 315(10), 839-846 (1982), "Stabilitasuntersuchungen and Phenylethylaminsubstituierten Pyrazolonein".
Chem. Abstracts, 73 (3) p. 361, No. 14777c (Jul. 20, 1970), "Diastereoisomeric Configuration of Morpholine Derivatives".
I.V. Bozhko, et al., Kinet. Katal., 31 (3), 737-738 (1990) (Russ.).
Lowe, et al., "The Discovery of (2S,3S)-cis-2(Diphenylmethyl)-N-(2-methoxyphenyl)methyl . . . ", J. Med. Chem., vol. 35, pp. 2591-2600 (1992).
McCormick, "Properties of Penodate-Oxidised Polysaccharides", J. Chem. Society, vol. C(23), pp. 2121-2127 (1966).
Montgomery, et al., "2-Fluoropurine Ribonucleosides", J. of Med. Chem., vol. 13(3), pp. 421-427 (1970).
Payan, et al., "Substance P. Recognition by a Subset of Human T Lymphocytes", J. Clin. Invest., 74, 1532-1539 (1984).
Peyronel, et al., "Synthesis of RP-67,580, a New Potent Nonpeptide Substance P Antagonist", Biorg. and Med. Chem. Lett., vol. 2(6), pp. 559-564 (1992).
Siemer, et al., "Analgesic 1-phenyl-2,3-dimethyl-4-morpholinomethyl-3-pyrazolin-5-ones . . . " Chem. Abstracts, 56, No. 6, No. 5977e (1962).
Chem. Abstracts, 113 (20) p. 123, No. 174441m (Nov. 12, 1990), "Amine Hydrochlorides--Catalysts for Hydrochlorination".
Laddlewahetty et al., Bioorg. Med. Chem., 4(16) 1917-20, 1994.
Chambers Mark Stuart
Dorn Conrad P.
Finke Paul E.
Hale Jeffrey J.
Harrison Timothy
Grumbling Matthew V.
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Morpholine and thiomorpholine tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpholine and thiomorpholine tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholine and thiomorpholine tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784160